Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.56 -0.03 (-1.16%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rocket Pharmaceuticals (RCKT) Long-Term Debt Issuances (2015)

Updated

Rocket Pharmaceuticals' Long-Term Debt Issuances came in at $52 million for FY2016, up 147.6% from $21 million in FY2015.

Analysis

Rocket Pharmaceuticals (RCKT) Long-Term Debt Issuances (2015) Analysis & Trends

  • Per Business Quant, earlier years put Long-Term Debt Issuances at $21 million in FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Rocket Pharmaceuticals 283.71 Mn 283.71 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 21.00 Mn
API Access

Rocket Pharmaceuticals Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=RCKT&period=max&api_key=YOUR_API_KEY